C9orf72重复扩张改变了行为变异前退行症和肌缩侧硬化症中二级运动和认知行为症状的风险
medRxiv : the preprint server for health sciences
|May 15, 2024
概括
C9orf72基因扩张显著增加了前退行症和ALS中发展二次症状的风险. 早期检测和协调护理对于这些患者至关重要.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 神经学 神经学
背景情况:
- 在行为变异前退行症 (bvFTD) 和肌缩侧面硬化症 (ALS) 中的次要症状缩短了生存期.
- 影响二次症状发展的因素尚不清楚.
研究的目的:
- 研究影响bvFTD和ALS中二次症状发展的因素.
- 评估C9orf72基因扩张对二次症状发作的影响.
主要方法:
- 对患有ALS (n=172) 和bvFTD (n=69) 个体的回顾性分析.
- 纳入标准:神经病理学证实TDP-43蛋白病变或C9orf72扩张.
- 统计分析包括二元物流回归和考克斯比例危险模型.
主要成果:
- 具有C9orf72扩张的个体具有显著更高的几率 (OR=4.25) 和发展次要症状的危险性 (HR=4.77).
- 最初的临床综合征 (bvFTD与ALS),发病年龄和性别与二次症状发展无关.
结论:
- C9orf72扩张是bvFTD和ALS中二级运动和认知行为症状的重要危险因素.
- 临床人员的警对于早期检测C9orf72扩张载体中的二次症状至关重要.
- 认知和神经肌肉诊所之间的协调护理可以改善这些患者的临床管理.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Parkinson's Disease: Overview
533
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
533


